What is the number of analysts for BIOS stock?
The number of analysts covering BIOSENIC SA (BIOS.BR) is 9.
BIOSENIC SA (BIOS.BR) Forecast, Price Target & Analyst Ratings
EBR:BIOS • BE0974280126
Current stock price
0.0022 EUR
0 (-8.33%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOSENIC SA (BIOS.BR).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of €0.00 to mean target of N/A, Based on 9 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
42.22%
BIOS.BR was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about BIOS.BR.
In the previous month the buy percentage consensus was at a similar level.
BIOS.BR was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | 1M -62.16% | 1M | N/A -100.00% | N/A | N/A | |
| EBITDA YoY % growth | N/A -240.00% | -14.416M 16.86% | -11.84M 17.87% | -9.996M 80.93% | 7.242M -199.25% | -18.36M 25.74% | |
| EBIT YoY % growth | N/A 47.37% | -15.017M -47.23% | -12.026M 19.92% | -11.832M 80.73% | -3.417M -201.98% | -18.564M 25.57% | |
| Operating Margin | N/A | -1,501.70% | -1,202.60% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A 36.32% | N/A 55.70% | N/A 7.58% | -0.08 86.89% | -0.01 87.50% | -0.05 -370.00% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A